Jeannette Bostedt, | |
2560 Business Pkwy, Minden, NV 89423-8985 | |
(408) 392-3403 | |
Not Available |
Full Name | Jeannette Bostedt |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 2560 Business Pkwy, Minden, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548933427 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Jeannette Bostedt, Po Box 94, Genoa, NV 89411-0094 Ph: (408) 313-8421 | Jeannette Bostedt, 2560 Business Pkwy, Minden, NV 89423-8985 Ph: (408) 392-3403 |
News Archive
The human body is proficient at making collagen. And human laboratories are getting better at it all the time. In a development that could lead to better drug design and new treatments for disease, Rice University researchers have made a major step toward synthesizing custom collagen. Rice scientists who have learned how to make collagen - the fibrous protein that binds cells together into organs and tissues - are now digging into its molecular structure to see how it forms and interacts with biological systems.
SUNY College of Optometry will take part in a multi-center US clinical trial sponsored by Eyenovia, Inc. to evaluate the safety and effectiveness of an investigational drug, MicroPine, to help slow myopic progression in children 3 to 12 years old.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Cancer patients who are malnourished experience significantly greater levels of psychological distress than those who are more adequately nourished, according to new results reported at the European Society for Medical Oncology's Symposium on Cancer and Nutrition (Zurich, 20-21 March 2009).
› Verified 1 days ago